|
 |
RapamycinThis page contains recent news articles, when available, and an overview of Rapamycin but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.This direct inhibition and dual activity differentiates INK128 from rapamycin and related analogs, or rapalogs, which predominately modulate TORC1 activity. ... PR Newswire (press release) Virus, cancer drug extends life of animal model with aggressive brain tumor - Dec 31, 2009 The researchers used Rapamycin, a drug approved by the US Food and Drug Administration to treat cancer. One of the affects of Rapamycin is to lower ... BCM News Human-like fossil find is breakthrough of the year - Dec 17, 2009 Others included the discovery that a compound called rapamycin boosted longevity in mice - the first time any drug has stretched a mammal's life span - and ... BBC News EGFR Signaling Through an Akt-SREBP-1–Dependent, Rapamycin-Resistant Pathway ... - Dec 16, 2009 Deliang Guo 1 , Robert M. Prins 2 , Julie Dang 1 , Daisuke Kuga 1 , Akio Iwanami 1 , Horacio Soto 2 , Kelly Y. Lin 1 , Tiffany T. Huang 1 , David Akhavan 1 ... Science Magazine (subscription) Longevity finding a top 2009 research breakthrough - Dec 23, 2009 Studies that showed rapamycin, an antibiotic used in transplant patients, extended the life span of aged mice at three separate US centers were recognized ... San Antonio Express Making Drugs Survive Longer in Blood - Dec 13, 2009 Amplyx's technology emerged from the study of a handful of large-molecule drugs, such as the immunosuppressant rapamycin, that are derived from microbes. ... MIT Technology Review (blog) How bone marrow transplant cures adult sickle cell disease - Dec 16, 2009 Powell's earlier research in mice showed that rapamycin inhibits an enzymatic pathway that suppresses the immune system and makes the host and donor cells ... The Guardian - Nigeria 'Notch'ing Up a Role in the Multisystem Disease Tuberous Sclerosis Complex - Dec 28, 2009 Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade. Journal of Clinical Investigation, ... Science Daily (press release) Sickle Cell Disease Reversed in Adults With Mini Stem Cell Transplants - Dec 10, 2009 Now, a new method of treatment researchers call, a non-myeloablative or “miniâ€? transplant, combined with an immune-suppressing drug called, rapamycin, ... ChattahBox Health: Kidney cancer a silent killer - Dec 28, 2009 The drug targets mammalian target of rapamycin (mTor) in cancer cells and inhibits its functions. Located inside the cell, mTor is a protein that is ... New Straits Times Getting a Handle on Posttransplant Recurrence of HCC - Dec 17, 2009 Sirolimus is an immunosuppressive agent that inhibits mammalian target of rapamycin (mTOR) and has been found to have antitumor effects in animal models of ... Cancer Network National academic journal honors San Antonio aging research - Dec 18, 2009 Dave Sharp, a professor of molecular medicine at the University of Texas Health Science Center at San Antonio, has discovered that rapamycin, an antibiotic ... MSN Money The Year in Biomedicine - Dec 21, 2009 Rapamycin, an antifungal drug currently used to prevent rejection of organ transplants, was found to boost longevity 9 to 13 percent even when it was given ... MIT Technology Review (blog) Semafore Pharmaceuticals Reports Encouraging Phase I Data At ASH For Novel ... - Dec 10, 2009 SF1126 is a novel small molecule inhibitor of phosphoinositide-3-kinase (PI3K) and mammalian target of rapamycin (mTOR), two key members of the PI3K ... Medical News Today (press release) Die Pille für neue Altersrekorde - Jan 1, 2010 Bakterien 1965 entdeckten Forscher auf den Osterinseln die Substanz Rapamycin, die vom Bakterium Streptomyces hygroscopicus gebildet wird. ... Kurier De viktigste nyhetene i 2009 - Dec 30, 2009 Jakten pÃ¥ ungdomskilden gikk videre, og Science peker pÃ¥ oppdagelsen av at stoffet rapamycin kan forlenge levealderen hos mus. ... forskning.no Die Fachzeitschrift »Science« kürt seit 20 Jahren ihre Entdeckung des Jahres - Jan 1, 2010 Rapamycin, ein Naturstoff von der Osterinsel, war bereits am 8. August Gegenstand unserer Biolumne: Mäuse, deren Futter die Substanz beigemischt war, ... Neues Deutschland Science-Liste 2009: Die zehn wichtigsten Entdeckungen des Jahres - Dec 17, 2009 Ebenfalls zu den zehn wichtigsten Entdeckungen des Jahres zählt die von Rapamycin, einem Naturstoff von der Osterinsel. Er könnte eine neue Arznei für ein ... FOCUS Online Haciendo que los fármacos sobrevivan más tiempo en la sangre - Dec 18, 2009 La tecnologÃa de Amplyx surgió del estudio de un grupo de fármacos de grandes moléculas, tales como el inmunosupresor rapamycin, derivadas de microbios. ... AlianzaTex Avances biomédicos más destacados del año - Dec 29, 2009 El fármaco conocido como Rapamycin, utilizado comúnmente para prevenir el rechazo a órganos transplantados, fue analizado y se descubrió que puede ayudar a ... El Golfo Info Drei Forscher der MedUni Wien ausgezeichnet - Dec 14, 2009 Der Nephrologe der MedUni Wien beschäftigte sich mit unerwünschten Nebenwirkungen des Medikaments Rapamycin nach Organtransplantationen. ... derStandard.at 科技脉动：长生ä¸?è€?è?¯ - Dec 18, 2009 ...å¤?æ™®å?šå£«è§£é‡Šè¯´ï¼šâ€œå?¡è·¯é‡ŒæŽ§åˆ¶æ˜¯ç»?ç”±mTOR途径(Mammalian Target of Rapamycin Pathway)产生作用的。而在å?¡è·¯é‡ŒæŽ§åˆ¶å½“ä¸ï¼Œå¯¹mTOR途径当ä¸çš„活动产生调é™?作用，而既然这个 ... 大纪元 Früh auf den Beinen - Dec 17, 2009 Rapamycin ist ein ringförmiges Molekül, hergestellt von einem Bakterium namens Streptomyces hygroscopicus, das erstmals in einer Bodenprobe von der ... Tagesspiegel Az év legnagyobb durranásai! - Jan 4, 2010 Kimutatták, hogy a rapamycin nevű vegyület meghosszabbÃtja az egerek életét, ráadásul a kezelést a kÃsérleti állatok csak középkorukban kapták meg. 5. ... Stop.hu 09《科å¦ã€‹å??大çª?ç ´ä¹‹â€œé•¿ç”Ÿä¸?è€?è?¯â€? - Dec 17, 2009 ...è¿™ä¸ªç ”ç©¶ä»¥è®ºæ–‡çš„å½¢å¼?å?‘表在了今年7月的《Nature》æ?‚å¿—ä¸Šï¼Œæ–‡ç« Rapamycin fed from 20 months of age extends lifespan in genetically heterogeneous mice。 ... 生物通 今年10大科å¸æˆ?å°±_雅蒂最亮眼 - Dec 18, 2009 ...延年益壽：專家發ç?¾ï¼Œã€Œé›·å¸•é»´ç´ ã€?（rapamycin）å?¯ä»¥å»¶é•·å°?é¼ çš„å£½å‘½ã€‚ .「至尊ã€?導體：æ??料科å¸å®¶é‘½ç ”出石墨烯的屬性，發ç?¾é€™ç¨®ç¢³åŽŸå?單層體傳導性極高。 ... 中時電子報 Tajomstvo protirakovinovej huby - Dec 29, 2009 Pri vysokých dávkach narúša samotnú výrobu bielkovÃn cez tlmenie biochemickej signálnej dráhy mTOR, Ä?o je skratka z anglického mammalian target of rapamycin ... OrangePortal أهم الاكتشاÙ?ات العلمية لعام 2009 - Dec 18, 2009 وأوضØت الصØÙŠÙ?Ø© أن الدواء الذى يطيل العمر الذى يسمى Rapamycin رابيماسين يمثل الاكتشاÙ? الثالث، Øيث قام علماء أمريكيين باختبار هذا الدواء على Øياة الÙ?ئران ووصل ... اليوم السابع ÉV VÉGI ÖSSZEFOGLALÓ: TERMÉSZETUDOMÃ?NY, TECHNIKA 2009 - Dec 28, 2009 A sziget polinéz neve, Rapa Nui után elnevezett "rapamycin" vegyület a középkorú egerek várható hátralévõ élettartamát a teljes életkor 28 százalékáról 38 ... Szabolcs Online 2009-12-21TvÃ¥ medicinska upptäckter tas med när tidskriften Science listar ... - Dec 21, 2009 Det handlar dels om det immundämpande läkemedlet rapamycin, eller sirolimus, som normalt används mot organavstötning vid njurtransplantationer. ... Dagens Medicin 10 phát hiện khoa há»?c tiêu biểu nhất năm 2009 - Dec 20, 2009 Hợp chất rapamycin giúp kéo dà i tuổi thá»? của chuá»™t thêm từ 9-14%, mở ra hi vá»?ng "trÆ°á»?ng sinh bất lão" cho con ngÆ°á»?i; việc phân láºp được hormone abscisis ... Báo Hoà Bình SÃ¥ fÃ¥r du lÃ¥ngt, lugnt liv - Dec 22, 2009 Nu hoppas mÃ¥nga i stället pÃ¥ ett piller med rapamycin, som redan används i vÃ¥rden i dag för att förhindra organavstötning. Den ansedda tidskriften Nature ... Kristianstadsbladet Hominid Terobosan Terbesar Sains 2009 - Dec 19, 2009 Ini adalah pertama kalinya obat penekan kekebalan tubuh yakni Rapamycin, telah terbukti bekerja pada mamalia. Seiring dengan perubahan iklim di puncak ... Inilah.com Hóa thạch giống ngÆ°á»?i là phát hiện khoa há»?c lá»›n nhất của năm - Dec 18, 2009 ...phát hiện vá»? hợp chất được gá»?i là rapamycin, được cho là giúp kéo dà i tuổi thá»? ở chuá»™t; những tiến bá»™ trong thuyết di truyá»?n có thể giúp Ä‘iá»?u trị má»™t ... Hà Nội Mới Mesothelioma Treatment Improved with Addition of Sirolimus - Nov 12, 2009 Sirolimus, which is also known as rapamycin, is an immunosuppressant drug traditionally used to prevent rejection of organ transplantations (especially used ... Asbestos.com New 'Schizophrenia Gene' Prompts Researchers To Test Potential Drug Target - Oct 27, 2009 The rescue, described as "surprisingly complete" by the researchers, was accomplished with rapamycin, a drug known to act on a protein called mTOR whose ... Science Daily (press release) Rapamuneâ„¢ May Improve Responses to Gleevec® in Patients with Chordoma - Nov 4, 2009 Researchers from Italy have reported that the addition of Rapamune® (sirolimus, rapamycin) to Gleevec® (imatinib) may improve disease control in patients ... Cancer Consultants Novel schizophrenia gene seems to prompt scientists to test possible drug target - Oct 30, 2009 They were noted to have described the rescue as 'surprisingly complete' which was achieved with rapamycin. Rapamycin is known to be a drug that acts on a ... HealthJockey.com Report Highlights Cancer Advances - Nov 9, 2009 Everolimus (Afinitor), an inhibitor of mammalian target of rapamycin (mTOR) demonstrated activity in patients whose cancer had not responded to prior ... MedPage Today Researchers Reconstitute Enzyme That Synthesizes Cholesterol Drug Lovastatin - Nov 9, 2009 Polyketides represent a class of 7000 known structures, of which more than 20 are commercial drugs, including the immunosuppressant rapamycin, ... Science Daily (press release) Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy - Oct 27, 2009 The mammalian target of rapamycin (mTOR) is an intracellular serine/threonine protein kinase positioned at a central point in a variety of cellular ... 7thSpace Interactive (press release) Torisel® Active in Relapsed or Refractory Mantle Cell Lymphoma - Oct 21, 2009 Torisel is a dihydroester of rapamycin that inhibits mTOR (mammalian target of rapamycin), a kinase enzyme. Treatment with Torisel leads to cell cycle ... Cancer Consultants Emerging evidence of a link between the polycystins and the mTOR pathways - Oct 28, 2009 Increased activity of the mammalian target of rapamycin (mTOR) kinase has been observed in cysts found in ADPKD tissues. Rapamycin has been shown to have ... 7thSpace Interactive (press release) Resistance to targeted therapy in renal-cell carcinoma - Abstract - Nov 1, 2009 Therapeutic targeting of integral biological pathways, including those involving vascular endothelial growth factor (VEGF) and mammalian target of rapamycin ... UroToday Reply to comment - Oct 23, 2009 ...b) treatment of fibrofolliculomas with topical rapamycin and; c) another genetic study of patients with inherited urologic malignancies. ... ScienceBlog.com (blog) New treatment approaches in renal cell carcinoma - Abstract - Oct 20, 2009 ...axitinib, pazopanib), antivascular endothelial growth factor agents (bevacizumab), and mammalian target of rapamycin inhibitors (temsirolimus, ... UroToday A Small Sip from the Fountain of Youth - Nov 6, 2009 ...of proteins and signaling molecules are being investigated, including the well-known diabetes drug metformin and the immunosuppressant rapamycin. ... Brain Blogger (blog) MacuSight(R) Receives Fast Track Designation From FDA for Perceiva(TM) in ... - Oct 21, 2009 ...including sirolimus (rapamycin), for minimally invasive, sustained, local administration to treat a number of major sight-threatening diseases. ... Reuters Incidence of Kidney Cancer Increasing - Oct 29, 2009 Temsirolimus (Torisel), another targeted drug, acts by inhibiting an enzyme inside the cell called mammalian target of rapamycin (mTOR); this treatment has ... Space Coast Medicine and Healthy Living Yale Researchers Awarded Grant to Develop Treatment of Williams Syndrome - Oct 28, 2009 ...“Drugs that inhibit mTORC1, such as rapamycin, are currently used in heart transplant patients and also to coat metal stents that open blocked coronary ... Media Newswire (press release) Rezept für den Jungbrunnen - Oct 21, 2009 Rapamycin heißt das Wundermittel. Es verdankt seinen Namen den Osterinseln, die in der Inselsprache Rapa nui heißen. Dort wurde die Substanz gefunden, ... Tagesspiegel Les meilleures actus du mois de novembre - Nov 2, 2009 Il suffirait de désactiver un gène, codant la protéine TOR (target of rapamycin) ou la protéine S6 kinase 1 (S6K1) qui y est reliée, pour bénéficier de la ... CareVox Wirksamkeit von Naturstoffen - Oct 30, 2009 Weltweit bekannt wurde Leys Synthese der gegen Tumore wirksamen Verbindung Rapamycin. Zusätzlich entwickelte Ley zahlreiche Techniken zur Herstellung von ... Allgemeine Zeitung Mainz Combination of imatinib with rapamycin or RAD001 acts synergistically... - Jun 30, 2005 Correspondence: Professor J Duyster, Department of Internal Medicine III, Technical University of Munich, Ismaningerstrae 22, D-81675 Munich, Germany. ... Nature.com Rapamycin activates Tap42-associated phosphatases by abrogating their... - Jul 27, 2006 The association of Tap42 with Tor2 is sensitive to rapamycin. Exponentially growing cells expressing HA-TOR2 (BY2470) were treated with (+) or without ... Nature.com … Kidney Disease; A study suggests that rapamycin can reverse growths - Mar 21, 2006 Scientists already knew that rapamycin inhibited mTOR, but they were not aware of ... Rapamycin is often used in the transplant to prevent organ rejection. ... Pay-Per-View - Los Angeles Times - ProQuest Archiver Neurological disorders: Magic with rapamycin - Mar 1, 2008 Tuberous sclerosis complex (TSC) is caused by heterozygous mutations in the TSC 1 or TSC 2 genes and is characterized by a broad range of symptoms, ... Nature.com Nutrient starvation promotes condensin loading to maintain rDNA... - Jan 4, 2007 ...(B) Condensin is required for rDNA condensation during rapamycin treatment. ... Early log-phase WT and ycs4-2 cells were treated with 200 nM rapamycin for 1 ... Nature.com Rapamycin treatment for a child with germline PTEN mutation - Nov 1, 2007 Background A 9-month-old boy with Proteus syndrome and a de novo germline mutation in the tumor suppressor PTEN was referred to a specialist centre for ... Nature.com Rapamycin control of transgene expression from a single AAV vector in... - Sep 29, 2005 Correspondence: Dr BJ Baum, Bldg. 10, Room 1N113, MSC-1190, GTTB/NIDCR/NIH, 10 Center Drive, Bethesda, MD 20892-1190, USA. Salivary glands (SGs) appear to ... Nature.com Is there a role for oral rapamycin in restenosis prevention after... - May 22, 2006 Rodriguez AE et al. (2006) Oral rapamycin after coronary bare-metal stent implantation to prevent restenosis. The Prospective, Randomized Oral Rapamycin in ... Nature.com The mammalian target of rapamycin complex 2 controls folding and … - Jun 19, 2008 The TORC2 components are essential for Akt and PKC/II TM phosphorylation. (A) The TM phosphorylation of Akt and conventional PKC is insensitive to ... Nature.com Stem cellsGood, bad and reformable : Nature - May 25, 2006 In stem cells lacking PTEN, this proliferative stress leads to exhaustion of stem-cell numbers as self-renewal is reduced. c, The drug rapamycin inhibits ... Nature.com Figure - Nature Cell Biology - Feb 20, 2005 ...(b) Rapamycin inhibits S-phase entry of both wild-type and S6K1 -/- ;S6K2 -/- cells. ... Rapamycin treatment was during the last day of culture. ... Nature.com Making the paper: Karen Liu - Mar 1, 2007 When the drug rapamycin binds to the tag, however, it stabilizes the protein, ... The final test came when Liu and her colleagues gave rapamycin injections ... Nature.com Now, a ray of hope for autism patients - Jun 24, 2008 Rapamycin is well-known for targeting an enzyme involved in making proteins ... “This is the first study to demonstrate that Rapamycin can repair learning ... Times of India Adding estradiol to a polymer-free rapamycin-eluting stent is not … - Apr 2, 2007 Patients admitted to the hospital with acute coronary syndromes (ACS) are often treated with a catheter-based procedure known as percutaneous coronary ... News-Medical.net The mammalian target of rapamycin complex 2 controls folding and … - Jun 19, 2008 Model for Akt regulation by mTORC2. mTORC2 phosphorylates newly synthesized Akt at the TM (Thr450) site to facilitate carboxyl-terminal folding and to ... Nature.com Rapamycin activates Tap42-associated phosphatases by abrogating their... - Jul 27, 2006 Model for rapamycin-induced phosphatase activation. The Tap42–phosphatase complexes exist mainly on membrane structures through association with TORC1. ... Nature.com Regulation of G0 entry by the Pho80[ndash]Pho85 cyclin[ndash]CDK … - Nov 24, 2005 ...(E) Both phosphate starvation and rapamycin treatment reduce the extent of phosphorylation of the T1075 residue in Rim15. Exponentially growing rim15 (IP31) ... Nature.com Hope of breakthrough in treatment of brain disorder - May 8, 2007 Rapamycin is used as an immunosuppressant for transplant patients. ... They also enhanced the effect of rapamycin. "These compounds appear to be promising ... Scotsman Novel Pathway Identifies Rapamycin As Tumor Angiogenesis Inhibitor - Aug 16, 2006 New research has uncovered a signaling pathway sufficient to induce formation of abnormal tumor-like blood vessels in otherwise healthy, normal tissues. ... Medical News Today - Medical News Today (press release) Figure 5 : TOR signalling regulates mitotic commitment through the... - Oct 21, 2007 Rapamycin was added to strains expressing pyp2–myc with or without ... Cells were filtered into proline or added rapamycin for 20 min (lanes 4 and 5). ... Nature.com Rapamycin Hits the Target - Jun 20, 2008 Charles Sawyers and colleagues have conducted a small early-stage clinical study to assess target modulation by the small-molecule inhibitor rapamycin. ... Medscape Sohail F Tavazoie, Veronica A Alvarez, Dennis A Ridenour, David J … - Nov 6, 2005 ...(c) Summary of measured spine density, length, head size and soma area following application of rapamycin. Shaded areas indicate the mean 2 sem of each ... Nature.com Figure 3 : Microarray-based method for monitoring yeast overexpression... - Jan 15, 2006 Overexpression of FPR1 resensitized the rapamycin-resistant yeast strain to rapamycin, confirming that the resistance-conferring mutation is associated with ... Nature.com Constitutive mTOR activation in TSC mutants sensitizes cells to... - Oct 25, 2007 Rapamycin does not affect p53 stability or phosphorylation. ... Addition of rapamycin 30 min before cycloheximide treatment did not affect p53 stability or ... Nature.com TOR regulates late steps of ribosome maturation in the nucleoplasm... - Aug 3, 2006 Rapamycin sensitivities and Nog1 protein levels of nog1-ts mutants. (A) Rapamycin-sensitive growth of nog1-11 and nog1-12. Serially diluted cells of NOG1 ... Nature.com The Effect of Rapamycin on DNA Synthesis in Multiple Tissues from... - Jun 9, 2008 Rapamycin is a potent antiproliferative agent that arrests cells in the G1 phase of the cell cycle through a variety of mechanisms involving the inhibition ... AJP - Cell Physiology (subscription) B lymphocyte–directed immunotherapy promotes long-term islet allograft... - Oct 28, 2007 One macaque (CR14) was normoglycemic for >1300 d after rapamycin ... Recipients in which rapamycin was discontinued developed alloantibodies, ... Nature.com Insulin delays the progression of Drosophila cells through G2/M by … - Dec 21, 2006 Inhibiting the dTOR/dRaptor complex with rapamycin promotes progression from ... The ability of rapamycin to accelerate progression from S phase through G2 ... Nature.com Immunoregulatory functions of mTOR inhibition - Apr 1, 2008 A complex formed between the immunosuppressive drug rapamycin and the immunophilin ... mTOR in mTORC1 is highly sensitive to inhibition by rapamycin, ... Nature.com Oncology; Tumor location guides the approach of rapamycin against … - Apr 4, 2005 ..."Rapamycin has previously been shown to be efficacious against intracerebral glioma xenografts and to act in a cytostatic manner against gliomas. ... Pay-Per-View - Clinical Oncology Week - Factiva, from Dow Jones Rapamycin activates Tap42-associated phosphatases by abrogating their... - Jul 27, 2006 Tap42 is phosphorylated only when it is associated with TORC1. (A) Exponentially growing cells (Y959) were metabolically labeled with 32 P and lysed. ... Nature.com Rapamycin study is first stage in development of new treatment - Aug 23, 2007 Rapamycin isn't your ordinary potential anti-cancer drug…It had a long and somewhat exotic history before undergoing preclinical (laboratory-based) studies ... News-Medical.net Surprise Finding Identifies Ways to Fight African Sleeping Sickness - Sep 8, 2008 TOR is so named because it is the target of rapamycin, a drug that causes ... Scientists had previously found that rapamycin was ineffective against the ... HealthNewsDigest.com Rapamycin Analog Boosts Cisplatin"s Antitumor Effectiveness - Mar 31, 2005 By Anne Harding. NEW YORK MAR 31, 2005 (Reuters Health) - A rapamycin derivative now in phase II trials for treating advanced cancer sensitizes tumor cells ... Cancerpage.com Rapamycin activates Tap42-associated phosphatases by abrogating their... - Jul 27, 2006 Tap42 is in complex with TORC1. (A) Extracts from cells expressing HA-Tor2 (BY2470) were fractionated into soluble (S 100 ) and membrane (P 100 ) fractions. ... Nature.com Acute Lymphoblastic Leukemia; Rapamycin stimulates apoptosis of … - Oct 11, 2005 According to a study from Italy, "The phosphatidyl-inositol 3 kinase (PI3k)/Akt pathway has been implicated in childhood acute lymphoblastic leukemia (ALL). ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones The effect of rapamycin on DNA synthesis in multiple tissues from... - Sep 28, 2007 Rapamycin is a potent antiproliferative agent that arrests cells in the G1 phase of the cell cycle through a variety of mechanisms involving the inhibition ... AJP - Cell Physiology (subscription) Rapamycin has no effect on fibrosis-associated gene expression or … - Mar 1, 2008 ...* Address for reprints: Mr Gavin J. Murphy, Specialist Registrar, Department of Cardiac Surgery, Bristol Royal Infirmary, Marlborough St, Bristol, ... The Journal of Thoracic and Cardiovascul... Organ-transplant drug might fight lupus - Aug 16, 2007 ..."We found that an analog of rapamycin is very effective in improving all aspects of the disease in lupus-prone mice," said Dr. Chandra Mohan, professor of ... United Press International Cancer Therapy; Dose optimization enables rapamycin to suppress tumor... - Apr 8, 2005 2005 APR 8 - (NewsRx.com) -- Dose optimization enables rapamycin to suppress ... According to recent research from Germany, "rapamycin has antiangiogenic ... Pay-Per-View - Angiogenesis Weekly - Factiva, from Dow Jones FDA accepts MacuSight drug application - Aug 8, 2006 Sirolimus, originally named rapamycin, is an immunosuppressant that can affect angiogenesis, the growth of new blood vessels. Wet AMD is caused by the rapid ... Bizjournals.com Cancer Therapy; Dose optimization enables rapamycin to suppress tumor... - Apr 4, 2005 2005 APR 4 - (NewsRx.com) -- Dose optimization enables rapamycin to suppress ... According to recent research from Germany, "rapamycin has antiangiogenic ... Pay-Per-View - Gastroenterology Week - Factiva, from Dow Jones Antitumor Activity Of Rapamycin In Glioblastoma - Jan 21, 2008 In a clinical trial published this week in PLoS Medicine, Charles Sawyers and colleagues looked at the safety of a drug called rapamycin in a selected group ... Medical News Today - Medical News Today (press release) RAPping production of type I interferon in pDCs through mTOR - Jul 1, 2006 The effect of rapamycin is not limited to pDCs, as the production of IL-10, IL-6 and tumor necrosis factor is also impaired in bone marrow–derived DCs ... Nature.com Cancer Therapy; Dose optimization enables rapamycin to suppress tumor... - Apr 4, 2005 2005 APR 4 - (NewsRx.com) -- Dose optimization enables rapamycin to suppress ... According to recent research from Germany, "rapamycin has antiangiogenic ... Pay-Per-View - Clinical Oncology Week - Factiva, from Dow Jones Figure - Nature Cell Biology - Jun 25, 2006 ...starved for 3 h in the absence or presence of 10 mM 3-methyladenine or treated with or without 2 M rapamycin or rapamycin + 10 mM 3-methyladenine. ... Nature.com Rapamycin does not improve insulin sensitivity despite elevated … - May 16, 2008 Andrew M. Miller, Jonathan R. Brestoff, Charles B. Phelps, E. Zachary Berk, and Thomas H. Reynolds, IV. Studies of cultured cells have indicated that the ... AJP-Regul Integr Comp Physiology... ISAR-PEACE: The Addition of Estradiol to a Rapamycin-Eluting Stent - Apr 30, 2007 The results from ISAR-PEACE are similar to those seen previously with estradiol-alone eluting stents. Delayed reendothelization is associated with an ... Medscape Cancer Therapy; Dose optimization enables rapamycin to suppress tumor... - Apr 4, 2005 2005 APR 4 - (NewsRx.com) -- Dose optimization enables rapamycin to suppress ... According to recent research from Germany, "rapamycin has antiangiogenic ... Pay-Per-View - Cancer Vaccine Week - Factiva, from Dow Jones … ; New components of target of rapamycin signaling network reported - Feb 21, 2005 2005 FEB 21 - (NewsRx.com & NewsRx.net) -- Researchers are finding new components of the target of rapamycin (TOR) signaling network through chemical ... Pay-Per-View - Proteomics Weekly - Factiva, from Dow Jones Cancer therapy: A role for MAPK inhibitors combined with mTORC1 … - Aug 22, 2008 Nearly a decade ago, while it was being tested as an immunosuppressive agent to prevent organ rejection in transplant patients, the drug rapamycin was also ... PhysOrg.com Rapamycin Shown to Inhibit Angiogenesis - Aug 11, 2006 Newswise — Scientists have long known that the blood vessels of tumors differ markedly from normal blood vessels. Now, a research team led by scientists at ... newswise.com Apoptosis; PHA665752 cooperated with rapamycin to inhibit lung … - Aug 2, 2005 ..."Here, we characterized a small molecule c-MET inhibitor, PHA665752, and tested its cooperation with the mammalian target of rapamycin inhibitor as ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Anti-Rejection Drug Has Heart Benefit - Jul 6, 2006 Virginia researchers said Wednesday the anti-rejection drug rapamycin might ... Rapamycin may one day be beneficial as a potential therapeutic strategy to ... RedOrbit Holding back TOR advances mitosis - Nov 1, 2007 TOR (target of rapamycin) is a highly conserved protein kinase that ... Interestingly, whereas only TORC2 was thought to be rapamycin sensitive in S. pombe, ... Nature.com … into a Research and License Agreement with Wyeth for Novel Rapamycin... - Oct 5, 2006 This alliance is focused on the discovery, development and commercialization of novel rapamycin analogs that target diseases in multiple therapeutic areas. ... Genetic Engineering News - Genetic Engineering News (press release) Rapamycin Analog AP23573 Crosses Blood-Brain Barrier and Targets … - Nov 16, 2005 By Maggie Schwarz. PHILADELPHIA, PA -- November 16, 2005 -- In a dose escalation study performed in patients undergoing debulking surgery for recurrent ... DG News … ; New components of target of rapamycin signaling network reported - Feb 26, 2005 2005 FEB 26 - (NewsRx.com & NewsRx.net) -- Researchers are finding new components of the target of rapamycin (TOR) signaling network through chemical ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones MacuSight reports positive phase 1 results for sirolimus - Feb 25, 2008 The trial assessed the safety, tolerability and biological activity of sirolimus (rapamycin) administered either subconjunctivally or intravitreally to 30 ... OSN SuperSite Angioplasty; Rapamycin foils restenosis by blocking leukocytes and … - Feb 15, 2005 According to recent research from Germany, "rapamycin combines antiproliferative and anti-inflammatory properties and reduces neointima formation after ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Angioplasty; Rapamycin foils restenosis by blocking leukocytes and … - Feb 14, 2005 According to recent research from Germany, "rapamycin combines antiproliferative and anti-inflammatory properties and reduces neointima formation after ... Pay-Per-View - Stem Cell Week - Factiva, from Dow Jones Angioplasty; Rapamycin foils restenosis by blocking leukocytes and … - Feb 19, 2005 According to recent research from Germany, "rapamycin combines antiproliferative and anti-inflammatory properties and reduces neointima formation after ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones Grapefruit juice being tested in cancer research - May 22, 2007 Cohen so far has enrolled 12 patients in his rapamycin- grapefruit juice study, ... Relinski is on a relatively low dose of rapamycin, but Cohen said that ... Pay-Per-View - Chicago Tribune - ProQuest Archiver Chemical Genomic Screening Identifies Novel Therapeutic Strategies... - Oct 2, 2006 This comparison revealed that the compound rapamycin is an agent capable of potentially ... The researchers further demonstrated that rapamycin modulates a ... Medical News Today - Medical News Today (press release) Rapamycin; Rapamycin-induced aP2 may play a role in increased … - Apr 4, 2005 According to a report from the United States, "Rapamycin (Sirolimus) is a potent immunosuppressive drug that reduces renal transplant rejection. ... Pay-Per-View - Biotech Business Week - Factiva, from Dow Jones … silencing regulates mammalian target-of-rapamycin growth and... - Jun 16, 2006 System ASC amino acid transporter-2 (ASCT2) was previously demonstrated to be essential for human hepatoma cell growth and survival, as its silencing via ... AJP - Cell Physiology (subscription) Tumorapa 1: efficacy of rapamycin in secondary prevention of skin … - Jun 1, 2006 This study is currently recruiting patients. Verified and sponsored by Hospices Civils de Lyon. In a population of kidney transplant recipients having ... Free with registration - Journal of Drugs in Dermatology - AccessMyLibrary.com An Expert Interview With Dr. Josep Tabernero - Feb 10, 2006 One of the highlights was a discussion of a promising new target in cancer therapy, mTOR, (an acronym for the mammalian target for rapamycin). ... Medscape Biotica grants Wyeth $195M rapamycin license. - Oct 16, 2006 Biotica grants Wyeth $195M rapamycin license. Biotica Technology, a privately-held UK biotechnology company, has signed an exclusive research collaboration ... $9.94 - Pharma Marketletter - Alacra Store Interleukin-4 stimulates proliferation and growth of T-cell acute … - Jul 3, 2008 ...(h) T-ALL cells were cultured with IL-4 alone or with rapamycin, ... Rapamycin stimulates apoptosis of childhood acute lymphoblastic leukemia cells. ... Nature.com X-Cell Medical first to enter DES clinicals with estradiol - Aug 19, 2005 While X-Cell president and CEO Oded Ben-Joseph, PhD, believes that current DES drugs such as sirolimus, a rapamycin derivative used in Cordis' (Miami Lakes, ... Free with registration - Medical Device Week - AccessMyLibrary.com Twenty-Seven Percent Of Advanced Sarcoma Patients Experience … - Nov 18, 2005 The drug, AP23573, is a non-prodrug rapamycin analog that potentially inhibits the mammalian target of rapamycin (mTOR). In phase 1 clinical trials, ... DG News Angiotech to Acquire Afmedica - Sep 13, 2005 Also the transaction could potentially expand Angiotech's research platform with rapamycin in perivascular and other selected disease indications. ... TechFinance Temsirolimus Equivalent to Currently Used Chemotherapy in Metastatic ... - Nov 21, 2005 Dr. Oza and coinvestigators presented results of this phase 2 study of temsirolimus -- a derivative of rapamycin that inhibits mammalian target of rapamycin ... DG News Drugs show promise in fighting mental retardation - Jul 7, 2008 Scientists working on mice found that rapamycin, an organ-rejection drug, improved learning in those with tuberous sclerosis complex -- a condition linked ... SmartBrief For mTOR, Clarification and Confusion - Dec 1, 2006 The mammalian target of rapamycin (mTOR) was already an established player in ... TOR was originally found as a target to rapamycin, a drug used to suppress ... Scientist Value Of Stent-coating Drugs Questioned - Mar 30, 2007 Previous research has shown that rapamycin used in drug-eluting stents (DES) successfully reduces restenosis, or repetitive narrowing of the arteries. ... Medical News Today - Medical News Today (press release) Distinguishing Friend From Foe In The Battle Against Cancer - Sep 11, 2006 The Hunter and Verma team found that rapamycin did that by increasing NF-kB activity ... Rapamycin, an immunosuppressant used to block organ rejection after ... emaxhealth.com "Friend Or Foe" In The Battle Against Cancer - Sep 14, 2006 The Hunter and Verma team found that rapamycin did that by increasing NF-kB activity ... Rapamycin, an immunosuppressant used to block organ rejection after ... Medical News Today - Medical News Today (press release) Distinguishing Friend from Foe in the Battle Against Cancer - Sep 8, 2006 The Hunter and Verma team found that rapamycin did that by increasing NF-kB activity ... Rapamycin, an immunosuppressant used to block organ rejection after ... newswise.com Value Of Stent-coating Drugs Questioned - Apr 4, 2007 Previous research has shown that rapamycin used in drug-eluting stents (DES) successfully reduces restenosis, or repetitive narrowing of the arteries. ... sciencedaily.com New study shows antibiotic may protect the heart - Jun 7, 2006 Virginia Commonwealth University researchers studying rapamycin, ... “Rapamycin may one day be beneficial as a potential therapeutic strategy to limit cell ... innovations report - Innovations-Report Drug Prevents Abnormalities That Lead To Seizures, Mouse Study Shows - Apr 4, 2008 ..."If that's the case, rapamycin should decrease the chance of seizures by ... Normally the mice die at 3-4 months of age, but with regular rapamycin doses ... sciencedaily.com Antibiotic May Protect the Heart - Jul 5, 2006 ..."Rapamycin may one day be beneficial as a potential therapeutic strategy to ... Rapamycin blocks protein synthesis by inhibiting the mammalian target of ... newswise.com Figure 3 : Post-translational enzyme activation in an animal via... - Nov 26, 2006 Cells were then treated with 0.1% DMSO or 100 nM rapamycin for 4 h at the indicated temperature before being lysed and assayed for luciferase activity. ... Nature.com Nf1 gene inactivation in acute myeloid leukemia cells confers... - Nov 24, 2005 Effect of rapamycin on Ara-C sensitivity of B114-GRD and B114-vect was determined by ... Rapamycin, an inhibitor of the upstream activator of eIF4E, mTOR, ... Nature.com Phospho-S6 ribosomal protein: a potential new predictive sarcoma … - Dec 21, 2007 Mammalian target of rapamycin (mTOR) is a ubiquitously expressed and highly ... The mechanisms of resistance to rapamycin-based mTOR inhibitors are not ... Nature.com Recent Studies Produce Promising Results in Effectively Treating... - Dec 11, 2005 Rapamycin -- used to help prevent the body from rejecting organ and bone marrow transplants by inducing programmed cell death (ie, an apoptotic effect) ... Free with registration - PR Newswire - AccessMyLibrary.com Cervical Cancer Therapy; New cervical cancer therapy study findings … - Nov 6, 2006 According to recent research from Toronto, Canada, "Clinical trials using rapamycin analogues or HER1/epidermal growth factor receptor (EGFR) inhibitors ... Pay-Per-View - OBGYN & Reproduction Week - Factiva, from Dow Jones Figure 4 : A clickable inhibitor reveals context-dependent autoactivat... - Jan 28, 2007 ...(a) Effect of rapamycin and fmk-pa on rpS6 phosphorylation. Serum-starved HEK 293 cells were treated with the indicated concentrations of rapamycin in the ... Nature.com Figure 7 : Novel targets for Huntington's disease in an mTOR- … - Mar 23, 2008 ...(g) Clearance of soluble EGFP-HDQ74 in stable PC12 cells as in Figure 1b, treated with or without 0.2 M rapamycin, 10 M calpastatin or both for the 48 h ... Nature.com Microarray-based method for monitoring yeast overexpression strains … - Jan 15, 2006 Specifically, the growth of Saccharomyces cerevisiae strains harboring 3900 different overexpression plasmids was monitored in the presence of rapamycin, ... Nature.com An Achilles heel in cancer cells - Dec 8, 2008 An FDA-approved chemotherapy drug called rapamycin can be used to arrest cell tumor growth. ... If the rapamycin target is hyperactive, Akt is inhibited, ... Genetic Engineering News - Genetic Engineering News (press release) An Achilles Heel in Cancer Cells - Dec 5, 2008 An FDA-approved chemotherapy drug called rapamycin can be used to arrest cell tumor growth. ... If the rapamycin target is hyperactive, Akt is inhibited, ... newswise.com Reversing Autism? - Jul 18, 2008 The UCLA researchers created a mouse model for TSC and tested Rapamycin, ... Rapamycin was chosen because it is known to target an enzyme involved in the ... Future of Things - The Future of Things Caught in a DIAGNOSTIC LIMBO, Five-year-old's tumor-causing condition... - Oct 24, 2006 In a recent animal experiment, Gutmann and his colleagues used an antibiotic, rapamycin [CORRECTION: A story Tuesday on Hunter Cavanaugh and his family's ... Pay-Per-View - Newsday - ProQuest Archiver Drug reverses mental retardation caused by genetic disorder - Jun 22, 2008 Using a mouse model for TSC, the scientists tested rapamycin, ... Rapamycin is well-known for targeting an enzyme involved in making proteins needed for ... Genetic Engineering News - Genetic Engineering News (press release) Autophagy-inducing agents augment the antitumor effect of telerase... - Jun 26, 2008 To test our hypothesis, we combined OBP-405 with rapamycin, an inhibitor of the ... 19, 20 Rapamycin and TMZ not only enhanced OBP-405-induced autophagy in ... Nature.com Biochemical monitoring of mTOR inhibitor–based immunosuppression … - Mar 20, 2005 Immunosuppressive therapy with the mammalian target of rapamycin (mTOR) ... SEHGAL, SN: Rapamune (RAPA, rapamycin, sirolimus): Mechanism of action ... Nature.com Juiced-Up Medicine - Jan 17, 2007 Rapamycin is approved by the Food and Drug Administration .. to stop the body ... But doctors also suspect Rapamycin could help shrink hard to treat tumors. ... go.com |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |